Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Colavita

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2023
Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN VaccineGiulia Matusali, Valentina Mazzotta, Pierluca Piselli, et al.
Frontiers in Immunology|June 17, 2022
Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment PathwayAlessandra D'Abramo, Serena Vita, Gaetano Maffongelli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 18, 2020
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization testSilvia Meschi, Francesca Colavita, Licia Bordi, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2021
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccineSilvia Meschi, Giulia Matusali, Francesca Colavita, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 27, 2022
Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysisGiuseppe Sberna, Lavinia Fabeni, Giulia Berno, et al.
Frontiers in Microbiology|March 30, 2022
<i>In vitro</i> Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2Giuseppe Sberna, Marco Biagi, Giovanni Marafini, et al.
Viruses|April 26, 2019
Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West AfricaFrancesca Colavita, Mirella Biava, Concetta Castilletti, et al.
Biomedicines|May 27, 2023
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital PersonnelAnnapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Non-Coding RNA|June 27, 2023
A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 ActivityFrancesco Greco, Elisa Lorefice, Claudia Carissimi, et al.
Mediators of Inflammation|July 4, 2018
ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMCFrancesca Colavita, Veronica Bordoni, Claudia Caglioti, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2023
Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN VaccineGiulia Matusali, Valentina Mazzotta, Pierluca Piselli, et al.
Frontiers in Immunology|June 17, 2022
Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment PathwayAlessandra D'Abramo, Serena Vita, Gaetano Maffongelli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 18, 2020
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization testSilvia Meschi, Francesca Colavita, Licia Bordi, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2021
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccineSilvia Meschi, Giulia Matusali, Francesca Colavita, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 27, 2022
Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysisGiuseppe Sberna, Lavinia Fabeni, Giulia Berno, et al.
Frontiers in Microbiology|March 30, 2022
<i>In vitro</i> Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2Giuseppe Sberna, Marco Biagi, Giovanni Marafini, et al.
Viruses|April 26, 2019
Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West AfricaFrancesca Colavita, Mirella Biava, Concetta Castilletti, et al.
Biomedicines|May 27, 2023
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital PersonnelAnnapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Non-Coding RNA|June 27, 2023
A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 ActivityFrancesco Greco, Elisa Lorefice, Claudia Carissimi, et al.
Mediators of Inflammation|July 4, 2018
ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMCFrancesca Colavita, Veronica Bordoni, Claudia Caglioti, et al.
Pageof 13